Business Daily.
.
A+ R A-

imageSAN DIEGO, Sept. 26, 2013 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the commercial launch of Herceptin® SC in Europe has triggered a $10 million milestone payment to Halozyme under the License and Collaboration Agreement between Halozyme and......


Page 1407 of 1908

Grow Your Business with Times Media
Business Daily Media